As indicated in the press release, Cannacord has the ability to sell an addional 15% of the stock in the event the issue is over subscribed. Would be a good sign to me if such happened. We should hear tomorrow or Wednesday.
Looked into subscribing for shares last week. They were already spoken for. This money will be spent for ramped up marketing and manufacturing of PINPOINT, LUNA and increased demand for SPY Elite (we have passed the 15% required for the AMA to declare "Standard of Care" for the 100k breast reconstructions in the US). They will need 100s not 10s of new personel to handle the explosive demand. I have breakeven this quarter and positive earnings next--not conting warrant expenses.
Anderson, what are you referencing when you mention the 15% for breast recon?
Arun on the cc mentioned 14% and growing 1% a quarter, I believe.
Also does anyone have a link to the transcript of the last cc?